Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Lissoni

Showing results (281-290 of 287) with videos related to

Pageof 29
Sort By:
You have reached the last page of results.This site can display upto 287 results.
Minerva Medica|December 6, 2006
Effect of acupressure on nausea and vomiting induced by chemotherapy in cancer patientsG Gardani, R Cerrone, C Biella, et al.
Anticancer Research|August 10, 2002
Ten-year survival results in metastatic renal cell cancer patients treated with monoimmunotherapy with subcutaneous low-dose interleukin-2P Lissoni, V Bordin, M Vaghi, et al.
Minerva Medica|February 27, 2008
A case-control study of Panicum Miliaceum in the treatment of cancer chemotherapy-induced alopeciaG Gardani, R Cerrone, C Biella, et al.
Journal of Biological Regulators and Homeostatic Agents|July 25, 1998
Physiopathology of IL-12 in human solid neoplasms: blood levels of IL-12 in early or advanced cancer patients, and their variations with surgery and immunotherapyP Lissoni, S Mengo, M Mandalà, et al.
Journal of Biological Regulators and Homeostatic Agents|August 15, 2001
Abnormally enhanced blood concentrations of vascular endothelial growth factor (VEGF) in metastatic cancer patients and their relation to circulating dendritic cells, IL-12 and endothelin-1P Lissoni, F Malugani, A Bonfanti, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|February 1, 1997
[Clinical response and survival in metastatic renal carcinoma during subcutaneous administration of interleukin-2 alone. Subcutaneous Il-2 in renal carcinoma]P Lissoni, S Barni, G Tancini, et al.
Urologia Internationalis|April 27, 2000
Five-year survival results of subcutaneous low-dose immunotherapy with interleukin-2 alone in metastatic renal cell cancer patientsV Bordin, L Giani, S Meregalli, et al.
Pageof 29

Showing results (281-290 of 287) with videos related to

Sort By:
Pageof 29
You have reached the last page of results.This site can display upto 287 results.
Minerva Medica|December 6, 2006
Effect of acupressure on nausea and vomiting induced by chemotherapy in cancer patientsG Gardani, R Cerrone, C Biella, et al.
Anticancer Research|August 10, 2002
Ten-year survival results in metastatic renal cell cancer patients treated with monoimmunotherapy with subcutaneous low-dose interleukin-2P Lissoni, V Bordin, M Vaghi, et al.
Minerva Medica|February 27, 2008
A case-control study of Panicum Miliaceum in the treatment of cancer chemotherapy-induced alopeciaG Gardani, R Cerrone, C Biella, et al.
Journal of Biological Regulators and Homeostatic Agents|July 25, 1998
Physiopathology of IL-12 in human solid neoplasms: blood levels of IL-12 in early or advanced cancer patients, and their variations with surgery and immunotherapyP Lissoni, S Mengo, M Mandalà, et al.
Journal of Biological Regulators and Homeostatic Agents|August 15, 2001
Abnormally enhanced blood concentrations of vascular endothelial growth factor (VEGF) in metastatic cancer patients and their relation to circulating dendritic cells, IL-12 and endothelin-1P Lissoni, F Malugani, A Bonfanti, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|February 1, 1997
[Clinical response and survival in metastatic renal carcinoma during subcutaneous administration of interleukin-2 alone. Subcutaneous Il-2 in renal carcinoma]P Lissoni, S Barni, G Tancini, et al.
Urologia Internationalis|April 27, 2000
Five-year survival results of subcutaneous low-dose immunotherapy with interleukin-2 alone in metastatic renal cell cancer patientsV Bordin, L Giani, S Meregalli, et al.
Pageof 29